Wednesday, June 24, 2020 CCTG is very pleased to announce that Dr. Dan Renouf has been awarded the CCTG Dr. Ralph Meyer Phase III Program Young Investigator Award. This award honours young investigators who have contributed significantly on CCTG phase III projects with CCTG Disease Site Committees, Endpoint Committees, or Working Groups. “I’m very honored to both be nominated for and to receive this award. The mentorship provided to me by many members within CCTG is very much appreciated," says Dr. Renouf. Dr. Renouf is a medical oncologist at BC Cancer, Vancouver Centre, and an Associate Professor at the University of British Columbia, Department of Medicine. He received his Doctor of Medicine from the University of Alberta and completed his internal medicine and medical oncology training at the University of British Columbia and BC Cancer. He undertook further training in early drug development and gastrointestinal oncology at the Princess Margaret Cancer Centre and the University of Toronto, and obtained a Masters of Public Health from Harvard University. Dr. Renouf’s research interests include developmental therapeutics, genomics, and biomarker development within gastrointestinal cancers, with a focus on pancreatic cancer. He is the leader of the BC Cancer Phase I program, the BC Cancer GI Tumour Group chair, the Co-Director of Pancreas Centre BC, and is the Co-chair of CCTG's Pancreatic Cancer disease group. Please join us in congratulating Dr. Renouf on this well-deserved recognition. For more information on the CCTG Awards and the 2020 honorees, please visit https://www.ctg.queensu.ca/public/recognition-awards.
